Search Results

There are 16616 results for: content related to: Epidermotropic secondary extramammary P aget's disease of the glans penis from retrograde lymphatic dissemination by transitional cell carcinoma of the bladder

  1. You have free access to this content
    Biosynthesis and immunobiochemical characterization of gp17/GCDFP-15

    European Journal of Biochemistry

    Volume 265, Issue 2, October 1999, Pages: 664–670, Emilia Caputo, Vitale Carratore, Marina Ciullo, Claudia Tiberio, Jean-Claude Mani, Dominique Piatier-Tonneau and John Guardiola

    Version of Record online : 25 DEC 2001, DOI: 10.1046/j.1432-1327.1999.00758.x

  2. Potent stimulatory effect of interleukin-1α on apolipoprotein D and gross cystic disease fluid protein-15 expression in human breast-cancer cells

    International Journal of Cancer

    Volume 59, Issue 3, 1 November 1994, Pages: 400–407, Yves Blais, Keiko Sugimoto, Marie-Claude Carriere, Darrow E. Haagensen, Fernand Labrie and Jacques Simard

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910590319

  3. Epidermotropic lesions: a review

    Journal of Cutaneous Pathology

    Volume 36, Issue 10, October 2009, Pages: 1037–1052, Ossama Abbas and Jag Bhawan

    Version of Record online : 23 JUL 2009, DOI: 10.1111/j.1600-0560.2009.01374.x

  4. GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups

    Histopathology

    Volume 67, Issue 1, July 2015, Pages: 96–105, Yun Bi Ni, Julia Y S Tsang, Siu Ki Chan and Gary M Tse

    Version of Record online : 21 JAN 2015, DOI: 10.1111/his.12625

  5. Mitogenic effect of the 15-kDa gross cystic disease fluid protein (GCDFP-15) on breast-cancer cell lines and on immortal mammary cells

    International Journal of Cancer

    Volume 60, Issue 2, 17 January 1995, Pages: 216–220, Paola Cassoni, Anna Sapino, Darrow E. Haagensen, Carlo Naldoni and Gianni Bussolati

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910600215

  6. You have free access to this content
    Differential antibody reactivity and CD4 binding of the mammary tumor marker protein GCDFP-15 from breast cyst and its counterparts from exocrine epithelia

    International Journal of Cancer

    Volume 78, Issue 1, 25 September 1998, Pages: 76–85, Emilia Caputo, Monica Autiero, Jean-Claude Mani, Stéphane Basmociogullari, Dominique Piatier-Tonneau and John Guardiola

    Version of Record online : 6 JAN 1999, DOI: 10.1002/(SICI)1097-0215(19980925)78:1<76::AID-IJC13>3.0.CO;2-3

  7. GATA-binding protein 3 enhances the utility of gross cystic disease fluid protein-15 and mammaglobin A in triple-negative breast cancer by immunohistochemistry

    Histopathology

    Volume 67, Issue 2, August 2015, Pages: 245–254, Lei Huo, Yun Gong, Ming Guo, Michael Z Gilcrease, Yun Wu, Hong Zhang, Jinxia Zhang, Erika Resetkova, Kelly K Hunt and Michael T Deavers

    Version of Record online : 23 FEB 2015, DOI: 10.1111/his.12645

  8. Cytokeratin 7: a re-evaluation of the ‘tried and true’ in triple-negative breast cancers

    Histopathology

    Volume 61, Issue 4, October 2012, Pages: 660–666, Simone M Davion, Kalliopi P Siziopikou and Megan E Sullivan

    Version of Record online : 2 JUL 2012, DOI: 10.1111/j.1365-2559.2012.04253.x

  9. Utility of GATA3 immunohistochemistry for diagnosis of metastatic breast carcinoma in cytology specimens

    Diagnostic Cytopathology

    Volume 43, Issue 4, April 2015, Pages: 271–277, David R. Braxton, Cynthia Cohen and Momin T. Siddiqui

    Version of Record online : 4 AUG 2014, DOI: 10.1002/dc.23206

  10. Diagnostic utility of mammaglobin and GCDFP-15 in the identification of metastatic breast carcinoma in fluid specimens

    Diagnostic Cytopathology

    Volume 37, Issue 7, July 2009, Pages: 475–478, Z. Yan, J. Gidley, D. Horton, J. Roberson, I. E. Eltoum and D. C. Chhieng

    Version of Record online : 13 FEB 2009, DOI: 10.1002/dc.21039

  11. Markers of metastatic carcinoma of breast origin

    Histopathology

    Volume 68, Issue 1, January 2016, Pages: 86–95, Allen M Gown, Regan S Fulton and Patricia L Kandalaft

    Version of Record online : 4 DEC 2015, DOI: 10.1111/his.12877

  12. Evaluation of androgen receptor and GATA binding protein 3 as immunohistochemical markers in the diagnosis of metastatic breast carcinoma to the lung

    Pathology International

    Volume 65, Issue 6, June 2015, Pages: 286–292, Yukinori Hattori, Akihiko Yoshida, Masayuki Yoshida, Masahide Takahashi and Koji Tsuta

    Version of Record online : 2 MAR 2015, DOI: 10.1111/pin.12278

  13. You have free access to this content
    Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical factors

    Cancer

    Volume 63, Issue 11, 1 June 1989, Pages: 2156–2161, Gwen Mazoujian, Carol Bodian, Darrow E. Haagensen JR and Cushman D. Haagensen

    Version of Record online : 29 JUN 2006, DOI: 10.1002/1097-0142(19890601)63:11<2156::AID-CNCR2820631115>3.0.CO;2-B

  14. You have free access to this content
    Circulating antibodies against the breast tumor marker GCDFP-15/gp17 in mammary carcinoma patients and in patients carrying benign breast conditions

    International Journal of Cancer

    Volume 84, Issue 6, 22 December 1999, Pages: 568–572, Rosa Pasquinelli, Pasquale Barba, Immacolata Capasso, Massimiliano D'Aiuto, Giuseppe D'Aiuto, Anna Maria Anzisi, Piergiuseppe De Berardinis and John Guardiola

    Version of Record online : 18 NOV 1999, DOI: 10.1002/(SICI)1097-0215(19991222)84:6<568::AID-IJC5>3.0.CO;2-G

  15. Comparative study of monoclonal antibody B72.3 and gross cystic disease fluid protein-15 as markers of apocrine carcinoma of the breast

    APMIS

    Volume 114, Issue 10, October 2006, Pages: 712–719, NAOKO HONMA, KAIYO TAKUBO, TOMIO ARAI, MAMOUN YOUNES, FUJIO KASUMI, FUTOSHI AKIYAMA and GOI SAKAMOTO

    Version of Record online : 28 SEP 2006, DOI: 10.1111/j.1600-0463.2006.apm_434.x

  16. Expression of GCDFP-15 and AR decreases in larger or node-positive apocrine carcinomas of the breast

    Histopathology

    Volume 47, Issue 2, August 2005, Pages: 195–201, N Honma, K Takubo, F Akiyama, M Sawabe, T Arai, M Younes, F Kasumi and G Sakamoto

    Version of Record online : 25 JUL 2005, DOI: 10.1111/j.1365-2559.2005.02181.x

  17. Gross cystic disease fluid protein-15 and mammaglobin A expression determined by immunohistochemistry is of limited utility in triple-negative breast cancer

    Histopathology

    Volume 62, Issue 2, January 2013, Pages: 267–274, Lei Huo, Jinxia Zhang, Michael Z Gilcrease, Yun Gong, Yun Wu, Hong Zhang, Erika Resetkova, Kelly K Hunt and Michael T Deavers

    Version of Record online : 11 SEP 2012, DOI: 10.1111/j.1365-2559.2012.04344.x

  18. A comparative immunohistochemistry study of diagnostic tools in salivary gland tumors: usefulness of mammaglobin, gross cystic disease fluid protein 15, and p63 cytoplasmic staining for the diagnosis of mammary analog secretory carcinoma?

    Journal of Oral Pathology & Medicine

    Volume 44, Issue 4, April 2015, Pages: 244–251, Fabrice Projetti, Magali Lacroix-Triki, Elie Serrano, Sebastien Vergez, Béatrice Herbault Barres, Julie Meilleroux, Marie-Bernadette Delisle and Emmanuelle Uro-Coste

    Version of Record online : 18 JUL 2014, DOI: 10.1111/jop.12226

  19. Interleukin-6 inhibits the potent stimulatory action of androgens, glucocorticoids and interleukin-1α on apolipoprotein D and GCDFP-15 expression in human breast cancer cells

    International Journal of Cancer

    Volume 62, Issue 6, 15 September 1995, Pages: 732–737, Yves Blais, Keiko Sugimoto, Marie-Claude Carrière, Darrow E. Haagensen, Fernand Labrie and Jacques Simard

    Version of Record online : 17 JUL 2006, DOI: 10.1002/ijc.2910620614

  20. Primary signet-ring cell/histiocytoid carcinoma of the axilla

    Pathology International

    Volume 63, Issue 7, July 2013, Pages: 374–376, Mitsuaki Ishida and Hidetoshi Okabe

    Version of Record online : 18 JUL 2013, DOI: 10.1111/pin.12071